Isabella Ciccone is an Associate Editor at Neurology Live. She specializes in medicine and healthcare, with a focus on topics such as gene therapy, immunotherapy, digital health, telehealth, and mental health care. Isabella's work has been featured in prominent publications including AJMC - The American Journal of Managed Care, Managed Healthcare Executive, and Contemporary OB/GYN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Isabella's coverage primarily focuses on neurology and healthcare & pharmaceutical topics, with an emphasis on citing data to support her articles. She may be interested in receiving pitches from experts who can provide insights into the latest research findings, clinical trials, or scientific developments within these areas.
Given the technical nature of Isabella's articles and her reliance on data, she is likely to respond well to pitches that offer expert commentary backed by credible research or statistical evidence. Pitches should demonstrate a clear understanding of the specific medical conditions and treatments discussed in her articles.
Since Isabella does not have a specified geographic focus, she appears open to covering international developments in neurology and healthcare without restriction to a particular region.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Lucy Morse, Isabella Ciccone
By: Isabella Ciccone
The randomized NATURE trial, presented as late-breaking science at ESC Congress 2026, showed that enVast-assisted thrombectomy reduced infarct size versus standard PCI in STEMI with large thrombus burden.
By: Isabella Ciccone
Newly published longitudinal fMRI data revealed that presymptom Huntington gene carriers had striatal network shifts up to 20 years early, potentially sharpening targets for studies in the future.
By: Isabella Ciccone
A recently published multiple sclerosis study suggests disease-modifying therapy use may be associated with higher rates of human papillomavirus positivity, cervical abnormalities, and other gynecologic complications.
By: Isabella Ciccone
Catch up on any of the neurology headlines you may have missed in August 2026, compiled into 1 place by the NeurologyLive® team.
By: Isabella Ciccone
Findings from a new study showed that over 90% of counties in the United States lacked a UCNS-certified headache specialist, with access lowest in socioeconomically disadvantaged and rural areas.
By: Isabella Ciccone
Olfactory dysfunction, dysautonomia, mood disturbance, and motor deficits disproportionate to dopaminergic denervation may serve as markers of amyloid-β positivity in newly diagnosed Parkinson disease.
By: Isabella Ciccone
Newly published KINECT-PRO data showed that valbenazine boosted quality of life and function while reducing movement severity, with remission for many patients with tardive dyskinesia by 24 weeks.
By: Isabella Ciccone
uniQure Submits BLA for Gene Therapy in HD, AAN, AHS Issue Updated Guideline on Migraine Prevention, CTE Prevalence, Brain Donation Findings in Former NFL Players
By: Isabella Ciccone
A recent study of Brazilian adolescents showed a high prevalence of excessive daytime sleepiness, with severe depressive symptoms and smartphone addiction emerging as the strongest independent risk factors.
